- Home
- PLX vs ACRE Comparison
PLX vs ACRE Comparison
Compare PLX & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLX | ACRE |
|---|---|---|
| Founded | 1993 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.1M | 191.4M |
| IPO Year | 1996 | 2011 |
Fundamental Metrics
Financial Performance| Metric | PLX | ACRE |
|---|---|---|
| Price | $2.56 | $3.43 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 754.6K | 662.4K |
| Earning Date | 08-12-2026 | 11-06-2026 |
| Dividend Yield | N/A | ★ 17.86% |
| EPS Growth | N/A | ★ 26.17 |
| EPS | 0.27 | ★ 1.35 |
| Revenue | $52,744,000.00 | ★ $54,833,000.00 |
| Revenue This Year | $55.77 | N/A |
| Revenue Next Year | N/A | $7.53 |
| P/E Ratio | $9.61 | ★ $2.49 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.65 | $3.16 |
| 52 Week High | $3.19 | $5.89 |
Technical Indicators
Market Signals| Indicator | PLX | ACRE |
|---|---|---|
| Relative Strength Index (RSI) | 47.34 | 40.14 |
| Support Level | $2.21 | N/A |
| Resistance Level | $2.75 | $3.69 |
| Average True Range (ATR) | 0.10 | 0.14 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 41.27 | 52.83 |
Price Performance
Historical ComparisonAbout PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a real estate investment trust mainly engaged in originating and investing in commercial real estate (CRE) loans and related investments. It operates in one segment, namely originating and managing a diversified portfolio of CRE debt-related investments. The company recognizes the majority of its revenues in the form of interest income, which it receives from loans.